Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Using outreach to improve colorectal cancer screening

This week's issue of the Journal of the American Medical Association investigates the effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion.

News image

Mailed fecal immunochemical test outreach is more effective than colonoscopy outreach for increasing 1-time colorectal cancer screening, but long-term effectiveness may need repeat testing and timely follow-up for abnormal results.

Dr Amit Singal and colleagues compared the effectiveness of fecal immunochemical test outreach and colonoscopy outreach to increase completion of the colorectal cancer screening process within 3 years.

The researchers performed a pragmatic randomized clinical trial from 2013 to 2016 among 5999 participants aged 50 to 64 years who were receiving primary care in Parkland Health and Hospital System and were not up to date with colorectal cancer screenings.

The participants were randomly assigned to mailed fecal immunochemical test outreach, mailed colonoscopy outreach, or usual care with clinic-based screening.

Screening process completion was 38% in the colonoscopy outreach group
Journal of the American Medical Association

Outreach included processes to promote repeat annual testing for individuals in the fecal immunochemical test  outreach group with normal results and completion of diagnostic and screening colonoscopy for those with an abnormal fecal immunochemical test result or assigned to colonoscopy outreach.

The researchers' primary outcome was screening process completion, defined as adherence to colonoscopy completion, annual testing for a normal fecal immunochemical test result, diagnostic colonoscopy for an abnormal fecal immunochemical test result, or treatment evaluation if colorectal cancer was detected.

Secondary outcomes included detection of any adenoma or advanced neoplasia, and screening-related harms.

All 5999 participants were included in the intention-to-screen analyses.

The research team observed that screening process completion was 38% in the colonoscopy outreach group, 28% in the fecal immunochemical test outreach group, and 11% in the usual care group.

Compared with the usual care group, the team found that between-group differences for completion were higher for both outreach groups, and highest in the colonoscopy outreach group.

Compared with usual care, the team noted that between-group differences in adenoma and advanced neoplasia detection rates were higher for both outreach groups, and highest in the colonoscopy outreach group.

There were no screening-related harms in any groups.

Dr Singal's team comments, "Among persons aged 50 to 64 years receiving primary care at a safety-net institution, mailed outreach invitations offering fecal immunochemical test or colonoscopy compared with usual care increased the proportion completing CRC screening process within 3 years."

"The rate of screening process completion was higher with colonoscopy than fecal immunochemical test outreach."

JAMA 2017;318(9):806-815
07 September 2017

Go to top of page Email this page Email this page to a colleague

 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us